Amneal Pharmaceuticals, LLC Selects Revitas Revenue Management Suite

Business News
Print
PHILADELPHIA--(BUSINESS WIRE)--Revitas, Inc., the leading provider of integrated solutions for contract, revenue, and compliance management, today announced that Amneal Pharmaceuticals (Amneal), one of the largest generic drug suppliers in the U.S., has selected the Revitas suite of revenue management solutions to support global growth and meet expanded business requirements. The suite of revenue management applications will be delivered on the strategic and standards-based Revitas® Flex® techn

imageimage
image

Read more